{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:02:17Z","timestamp":1762956137518,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jocn.2019.08.043","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T07:59:30Z","timestamp":1566806370000},"page":"199-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The efficacy and safety of lamotrigine for absence seizures in children and adolescents: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"71","author":[{"given":"Jing","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-xiao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Ming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2019.08.043_b0005","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(00)03600-X","article-title":"Neuropsychological effects of epilepsy and antiepileptic drugs","volume":"357","author":"Kwan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2019.08.043_b0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0079-6123(02)35034-9","article-title":"Assessing the behavioral and cognitive effects of seizures on the developing brain","volume":"135","author":"Stafstrom","year":"2002","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.jocn.2019.08.043_b0015","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1212\/01.WNL.0000115653.82763.07","article-title":"Cognitive side effects of antiepileptic drugs in children","volume":"62","author":"Loring","year":"2004","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jocn.2019.08.043_b0020","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/14656566.2018.1484902","article-title":"How to select the appropriate pharmacotherapy for absence seizures in children","volume":"19","author":"Mazzocchetti","year":"2018","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"10.1016\/j.jocn.2019.08.043_b0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.braindev.2015.10.007","article-title":"Lamotrigine monotherapy for newly diagnosed typical absence seizures in children: a multi-center, uncontrolled, open-label study","volume":"38","author":"Yasumoto","year":"2016","journal-title":"Brain Dev"},{"key":"10.1016\/j.jocn.2019.08.043_b0030","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2019.08.043_b0035","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa0902014","article-title":"Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy","volume":"362","author":"Glauser","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2019.08.043_b0040","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1528-1157.1999.tb00805.x","article-title":"Lamictal (lamotrigine) monotherapy for typical absence seizures in children","volume":"40","author":"Frank","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2019.08.043_b0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/088307380201700408","article-title":"Long-term tolerability and efficacy of lamotrigine in pediatric patients with epilepsy","volume":"17","author":"Duchowny","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jocn.2019.08.043_b0050","doi-asserted-by":"crossref","first-page":"264e9","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jocn.2019.08.043_b0055","unstructured":"Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration; 20. Available from: www.cochrane-handbook.org."},{"key":"10.1016\/j.jocn.2019.08.043_b0060","doi-asserted-by":"crossref","first-page":"557e60","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.jocn.2019.08.043_b0065","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1528-1157.1999.tb00805.x","article-title":"Lamictal (lamotrigine) monotherapy for typical absence seizures in children","volume":"40","author":"Frank","year":"1999","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.jocn.2019.08.043_b0070","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.0013-9580.2004.40903.x","article-title":"Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study","volume":"45","author":"Coppola","year":"2004","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.jocn.2019.08.043_b0075","first-page":"653","article-title":"Valproic acid versus lamotrigine as a monotherapy for absence epilepsy in children","volume":"11","author":"Huang","year":"2009","journal-title":"Zhongguo Dangdai Erke Zazhi"},{"issue":"14","key":"10.1016\/j.jocn.2019.08.043_b0080","first-page":"101","article-title":"Study on the efficacy of lamotrigine in the treatment of amnesia in children","volume":"27","author":"Zhang","year":"2012","journal-title":"Zhongguo Shequ Yishi"},{"issue":"1","key":"10.1016\/j.jocn.2019.08.043_b0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/epi.12028","article-title":"Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.jocn.2019.08.043_b0090","first-page":"549","article-title":"Comparison of lamotrigine and sodium valproate in the treatment of typical amnesia attack","volume":"23","author":"Li","year":"2008","journal-title":"Zhongguo Shiyong Erke Zazhi"},{"issue":"6","key":"10.1016\/j.jocn.2019.08.043_b0095","first-page":"277","article-title":"Comparative study of sodium valproate and lamotrigine as monotherapy in the management of typical absence seizures","volume":"46","author":"Basu","year":"2005","journal-title":"Epilepsia"},{"issue":"2\u20133","key":"10.1016\/j.jocn.2019.08.043_b0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eplepsyres.2008.07.016","article-title":"Lamotrigine monotherapy for newly diagnosed typical absence seizures in children","volume":"82","author":"Holmes","year":"2008","journal-title":"Epilepsy Res"},{"issue":"10","key":"10.1016\/j.jocn.2019.08.043_b0105","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.wnl.0000216273.94142.84","article-title":"Effect of lamotrigine on cognition in children with epilepsy","volume":"66","author":"Pressler","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2019.08.043_b0110","article-title":"Absence seizures in children","author":"Posner","year":"2013","journal-title":"BMJ Clin Evid"},{"issue":"6","key":"10.1016\/j.jocn.2019.08.043_b0115","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ejpn.2018.07.014","article-title":"A pilot study of add-on oral triheptanoin treatment for children with medically refractory epilepsy","volume":"22","author":"Calvert","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"10.1016\/j.jocn.2019.08.043_b0120","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ejpn.2018.07.001","article-title":"Multifocal epilepsy in children is associated with increased long-distance functional connectivity: an explorative EEG-fMRI study","volume":"22","author":"Siniatchkin","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jocn.2019.08.043_b0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1528-1157.2001.28899.x","article-title":"On the association between valproate and polycystic ovary syndrome","volume":"42","author":"Genton","year":"2001","journal-title":"Epilepsia"},{"issue":"Suppl 5","key":"10.1016\/j.jocn.2019.08.043_b0130","first-page":"149","article-title":"Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy","volume":"42","author":"Delgado-Escueta","year":"1992","journal-title":"Neurology"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586819312688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586819312688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:18:46Z","timestamp":1760822326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586819312688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":26,"alternative-id":["S0967586819312688"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2019.08.043","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of lamotrigine for absence seizures in children and adolescents: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2019.08.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}